An interventional study of Website access in Colorectal Cancer, sponsored by Berlin School of Public Health. Completed at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-11-10.
Sponsored by Berlin School of Public Health · Not applicable, Interventional, and Supportive care
Being diagnosed with cancer confronts patients with a severe disease and they need to learn to deal with a range of new challenges. In order to support patients in the coping process, the website www.krankheitserfahrungen.de provides patients free, reliable information about health issues by sharing peoples' real-life experiences. In our project, the investigators developed a new module on the website for patients with colorectal cancer.
The objective of our study is to evaluate if access to the new colorectal cancer module on the website www.krankheitserfahrungen.de increases patient's competence.
The investigators will conduct a two-arm randomized controlled trial. Patients affected by colorectal cancer will be randomized into an intervention and a control group: the intervention group will have access for two weeks to the website www.krankheitserfahrungen.de (colorectal cancer module) with cancer patients´ experiences. Patients in the control group will not receive any intervention but will have access to the website for two weeks after completing the study.
Patient competence is measured by the self-efficacy component of the German short form of the Cancer Behavior Inventory via an online questionnaire at baseline and after two weeks. A second follow-up assessment will be implemented six weeks after baseline.
5,598 studies on the registry are indexed under Colorectal Neoplasms; 1,458 are open to participants now.
This study's enrollment of 212 is above the median of 77 across 4,122 interventional studies indexed under Colorectal Neoplasms.
Browse Colorectal Neoplasms studies →Berlin School of Public Health is the lead sponsor of 2 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Two-week access to the colorectal cancer module of the website www.krankheitserfahrungen.de
Other: Website access
Participants who are randomized to the control group don't have access to the website until they have finished the last questionnaire at 6 weeks follow up.
Access to the colorectal cancer module of the website www.krankheitserfahrungen.de which provides free, reliable information about health issues by sharing people's real-life experiences
Self-efficacy for coping with cancer (measured by the German short form of the Cancer Behavior Inventory)
Time frame: after 2 weeks
Change in self-efficacy for coping with cancer (measured by the German short form of the Cancer Behavior Inventory)
Time frame: At baseline and after 2 weeks
Change in self-efficacy for coping with cancer (measured by the German short form of the Cancer Behavior Inventory)
Time frame: At baseline and after 6 weeks
Patient competence (assessed by a self-rating measure of patient competence in oncology in validation process)
Time frame: After 2 weeks
Patient competence (assessed by a self-rating measure of patient competence in oncology in validation process)
Time frame: After 6 weeks
This study is completed, as verified in Nov 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Berlin School of Public Health